Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease

被引:0
|
作者
Ishii, K
Sasaki, M
Yamaji, S
Sakamoto, S
Kitagaki, H
Mori, E
机构
[1] Hyogo Inst Aging Brain & Cognit Disorders, Div Neuroimaging Res, Himeji, Hyogo 670, Japan
[2] Hyogo Inst Aging Brain & Cognit Disorders, Div Clin Neurosci, Himeji, Hyogo 670, Japan
[3] Kobe Univ, Sch Med, Dept Radiol, Kobe, Hyogo 650, Japan
关键词
PET; Alzheimer's disease; oxygen-15-labeled water; hippocampus; cerebral blood flow;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose of this study was to clarify the changes in hippocampal perfusion in mild-to-moderate Alzheimer's disease using PET and O-15-labeled water. Methods: Sixteen patients with probable mild-to-moderate Alzheimer's disease (age: 68.1 +/- 11.3 yr; MMSE: 21.1 +/- 4.5) and 10 normal volunteers (age: 65.1 +/- 8.2 yr) were studied. Regional cerebral blood flow (CBF) and cerebral blood volume (CBV) were measured using (15)0-labeled water autoradiographic method, (CO)-O-15-gas inhalation technique and PET. Results: Although the mean CBF in the parietotemporal region was significantly lower in the patient group than in the control group, the mean CBF in the hippocampus did not show significant reduction between the two groups, both in absolute and relative values. There was no significant regional CBV difference between the two groups. Parietotemporal perfusion correlated well with cognitive scores, both in absolute and relative values, in Alzheimer's disease, but hippocampal perfusion did not correlate well. Conclusion: Hippocampal perfusion was preserved in mild-to-moderate Alzheimer's disease.
引用
收藏
页码:293 / 298
页数:6
相关论文
共 50 条
  • [41] Neuropsychophysiological evaluation of three doses of S 12024-2 in mild-to-moderate Alzheimer's disease
    Derouesne, C
    Renault, B
    VanderLinden, M
    Lacomblez, L
    Homeyer, P
    Ouss, L
    Neuman, E
    Malbezin, M
    Barrandon, S
    Guez, D
    CLINICAL DRUG INVESTIGATION, 1997, 14 (04) : 301 - 306
  • [42] Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate Alzheimer's disease
    Maynard, Steven Douglas
    Gelblum, Jeff
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1619 - 1627
  • [43] Dose Effects Associated with Rivastigmine Transdermal Patch in Patients with Mild-to-Moderate Alzheimer's Disease
    Grossberg, George T.
    Somogyi, Monique
    Meng, Xiangyi
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 19 (03): : S121 - S122
  • [44] Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab
    Russu, Alberto
    Samtani, Mahesh N.
    Xu, Steven
    Adedokun, Omoniyi J.
    Lu, Ming
    Ito, Kaori
    Corrigan, Brian
    Raje, Sangeeta
    Liu, Enchi
    Brashear, H. Robert
    Styren, Scot
    Hu, Chuanpu
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 (02) : 535 - 546
  • [45] Safety Profile of Bapineuzumab in a Phase II Trial of Mild-to-Moderate Alzheimer's Disease (AD)
    Honig, Lawrence S.
    Gilman, Sid
    Morris, Kristen
    Black, Ronald
    Grundman, Michael
    Francis, Gordon
    NEUROLOGY, 2009, 72 (11) : A272 - A272
  • [46] Gastrointestinal tolerability of once-daily galantamine in subjects with mild-to-moderate Alzheimer's disease
    Dunbar, F
    Zhu, Y
    Brashear, R
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 312 - 312
  • [47] Systolic blood pressure variability and subcortical hyperintensities in patients with mild-to-moderate Alzheimer's disease
    Correia, S
    Salloway, S
    Malloy, P
    Song, C
    Li, R
    NEUROBIOLOGY OF AGING, 2004, 25 : S278 - S279
  • [48] Effects of Transdermal Rivastigmine on ADAS-Cog Items in Mild-to-Moderate Alzheimer's Disease
    Grossberg, George T.
    Schmitt, Frederick A.
    Meng, Xiangyi
    Tekin, Sibel
    Olin, Jason
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2010, 25 (08): : 627 - 633
  • [49] Relationships of Fall Risk With Frailty, Sarcopenia, and Balance Disturbances in Mild-to-Moderate Alzheimer's Disease
    Oytun, Merve Guner
    Topuz, Semra
    Bas, Arzu Okyar
    Coteli, Suheyla
    Kahyaoglu, Zeynep
    Boga, Ilker
    Ceylan, Serdar
    Dogu, Burcu Balam
    Cankurtaran, Mustafa
    Halil, Meltem
    JOURNAL OF CLINICAL NEUROLOGY, 2023, 19 (03): : 251 - 259
  • [50] Dose effects associated with rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease
    Grossberg, G. T.
    Olin, J. T.
    Somogyi, M.
    Meng, X.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (04) : 465 - 471